These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Lanthanide complexes of triethylenetetramine tetra-, penta-, and hexaacetamide ligands as paramagnetic chemical exchange-dependent saturation transfer contrast agents for magnetic resonance imaging: nona- versus decadentate coordination. Burdinski D, Pikkemaat JA, Lub J, de Peinder P, Nieto Garrido L, Weyhermüller T. Inorg Chem; 2009 Jul 20; 48(14):6692-712. PubMed ID: 19507818 [Abstract] [Full Text] [Related]
26. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement. Ahrén M, Selegård L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K. Langmuir; 2010 Apr 20; 26(8):5753-62. PubMed ID: 20334417 [Abstract] [Full Text] [Related]
31. Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications. Helm L. Future Med Chem; 2010 Mar 28; 2(3):385-96. PubMed ID: 21426173 [Abstract] [Full Text] [Related]
32. Hybrid lanthanide nanoparticles with paramagnetic shell coated on upconversion fluorescent nanocrystals. Li Z, Zhang Y, Shuter B, Muhammad Idris N. Langmuir; 2009 Oct 20; 25(20):12015-8. PubMed ID: 19764797 [Abstract] [Full Text] [Related]
36. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI. Woessner DE, Zhang S, Merritt ME, Sherry AD. Magn Reson Med; 2005 Apr 20; 53(4):790-9. PubMed ID: 15799055 [Abstract] [Full Text] [Related]
37. New paramagnetic supramolecular adducts for MRI applications based on non-covalent interactions between Gd(III)-complexes and beta- or gamma-cyclodextrin units anchored to chitosan. Aime S, Gianolio E, Uggeri F, Tagliapietra S, Barge A, Cravotto G. J Inorg Biochem; 2006 May 20; 100(5-6):931-8. PubMed ID: 16412512 [Abstract] [Full Text] [Related]